Experienced in Angiosarcoma of the Liver

Eric M. Yoshida

Vancouver, BC, CA 
Experienced in Angiosarcoma of the Liver
Vancouver, BC, CA 
OverviewLocationsClinical Research

Overview

Eric Yoshida practices in Vancouver, Canada. Mr. Yoshida is rated as an Experienced expert by MediFind in the treatment of Angiosarcoma of the Liver. His top areas of expertise are Hepatitis, Hepatitis C, Cholangitis, Liver Transplant, and Endoscopy.

His clinical research consists of co-authoring 277 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Angiosarcoma of the Liver.

Gender
Male

Locations

Vancouver, BC, Canada
Other Locations
BC, Canada
Markham, ON L3R8T3, Canada
Ottawa, ON, Canada
Suite 801, 3100 Steeles Avenue East Markham, Steeles, ON L3R8T3, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
View 1 Less Clinical Trial

277 Total Publications

PPAR Agonists: The Next Innovation in Hepatology.
PPAR Agonists: The Next Innovation in Hepatology.
Journal: Canadian liver journal
Published: July 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Yoshida's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 41 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile